SCHEMBL8460971

SCHEMBL8460971

CCCC(C)(O)N1CCNCC1

nearest known ligand 0.33

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 2/20 0.33
GNAI3 P08754 2/20 0.32
GNAO1 P09471 2/20 0.32
GNAI1 P63096 2/20 0.32
FDPS P14324 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11039485 0.86 GNAO1 (0.41) SIGMAR1GNAI3GNAO1GNAI1FDPS
SCHEMBL28210518 0.84 SIGMAR1 (0.33) SIGMAR1
SCHEMBL22595095 0.82 FDPS (0.34) FDPS
SCHEMBL1408779 0.80 GNAI3 (0.33) SIGMAR1GNAI3GNAO1GNAI1
SCHEMBL757659 0.80 SIGMAR1 (0.33) SIGMAR1
SCHEMBL18499722 0.77 GNAO1 (0.34) SIGMAR1GNAI3GNAO1GNAI1
SCHEMBL9533096 0.77 SIGMAR1 (0.32) SIGMAR1GNAI3GNAO1GNAI1FDPS
SCHEMBL9434047 0.77 SIGMAR1 (0.39) SIGMAR1
SCHEMBL29204211 0.75 SIGMAR1 (0.32) SIGMAR1
SCHEMBL22734012 0.74 GNAI3 (0.32) GNAI3GNAO1GNAI1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0929612-A1 FLOOR FINISH COMPOSITIONS MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1999-07-21 EP claimed
WO-1998011168-A1 FLOOR FINISH COMPOSITIONS MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1998-03-19 WO claimed
US-20140350081-A1 INSECT G-COUPLED RECEPTORS USEFUL AS TARGETS FOR INSECTICIDES AND COMPOUNDS AND REAGENTS IDENTIFIED USING THE SAME US ARMY, SECRETARY OF THE ARMY 2014-11-27 US disclosed
US-20130137646-A1 METHODS OF TREATMENT, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2013-05-30 US disclosed
EP-0929612-A1 FLOOR FINISH COMPOSITIONS MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1999-07-21 EP disclosed
WO-1998011168-A1 FLOOR FINISH COMPOSITIONS MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1998-03-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140350081-A1 INSECT G-COUPLED RECEPTORS USEFUL AS TARGETS FOR INSECTICIDES AND COMPOUNDS AND REAGENTS IDENTIFIED USING THE SAME DDT, ADRA2C, MCHR1 SIGMAR1 190/4885GNAI3 106/4885GNAO1 75/4885
US-20130137646-A1 METHODS OF TREATMENT, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF SLC5A2, SLC5A1, SLC2A2 SIGMAR1 1639/4885GNAI3 1977/4885GNAO1 1936/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.